# Impact of Early Lactate Dosage Compared to CK for Diagnosis of a Suspected Seizure

> **NCT03163719** · — · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 100 (estimated)

## Conditions studied

- Epileptic Seizure
- Creatine Kinase
- Lactate
- Epileptic Generalized Tonic-clonic Seizure

## Interventions

- **DIAGNOSTIC_TEST:** CK and Lactate dosages

## Key facts

- **NCT ID:** NCT03163719
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11-28
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163719, "Impact of Early Lactate Dosage Compared to CK for Diagnosis of a Suspected Seizure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03163719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*